Zobrazeno 1 - 10
of 58
pro vyhledávání: '"E, Christe"'
Autor:
Jillian N. Noblet, Steven P. Moberly, Michael E. Christe, Zachary C. Berwick, Johnathan D. Tune, Hana E. Baker, Eli D. Casalini, Mark C. Kowala, Eugene Zhen, Adam G. Goodwill
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 318:H747-H755
This study tested the hypothesis that (pyr)apelin-13 dose-dependently augments myocardial contractility and coronary blood flow, irrespective of changes in systemic hemodynamics. Acute effects of intravenous (pyr)apelin-13 administration (10 to 1,000
Autor:
Liyun Ding, Matthew P. Coghlan, Ellen P.S. Conceição Furber, Jorge Alsina-Fernandez, Kyle W. Sloop, Brian A. Droz, Mridula Dogra, Annie M. Long, Michael E. Christe, Tamer Coskun, Ruth E. Gimeno, Xiaoping Ruan, Jill A. Willency, William C. Roell, Debra L. Konkol, Adrienne K. Holland, Ricardo J. Samms, Jessica L. Friedrich, Libbey S. O’Farrell, Valentina Pirro, Over Cabrera, Daniel A. Briere, Richard Cosgrove, Samantha Wojnicki, Kyla A.L. Collins, Julie S. Moyers, Yanzhu Lin, Christine C. Cheng
Publikováno v:
J Clin Invest
Tirzepatide (LY3298176), a dual GIP and GLP-1 receptor (GLP-1R) agonist, delivered superior glycemic control and weight loss compared with GLP-1R agonism in patients with type 2 diabetes. However, the mechanism by which tirzepatide improves efficacy
Autor:
Michael E. Christe
Ornithine decarboxylase (ODC) is the first and rate-limiting enzyme in the synthesis of polyamines, which play a regulatory role in nucleic acid and protein synthesis. The enzyme may be involved in normal and abnormal growth of the myocardium, in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee809bf83353bc3c8ec70111323fff96
https://doi.org/10.23860/thesis-christe-michael-1989
https://doi.org/10.23860/thesis-christe-michael-1989
Autor:
Julie S. Moyers, Ajit Regmi, Ricardo J. Samms, William C. Roell, Michael E. Christe, Xiaoping Ruan
Publikováno v:
Diabetes. 68
Tirzepatide (TZP), a GIP receptor and GLP-1 receptor (GIPR/GLP-1R) dual agonist, has demonstrated profound effects on glycemic control and bodyweight lowering in T2D subjects. However, the mechanism of action for the dual agonism of TZP is incomplete
Autor:
Arthur Christopoulos, Patrick M. Sexton, Lachlan Clydesdale, Asuka Inoue, Yi Lynn Liang, Giuseppe Deganutti, Tin T. Truong, Matthew J. Belousoff, Michael E. Christe, Sebastian G.B. Furness, Michael Gregory Bell, Christopher A. Reynolds, Denise Wootten, Kyle W. Sloop, Ming-Wei Wang, Francis S. Willard, Peishen Zhao, Laurence J. Miller, Madeleine M. Fletcher, Radostin Danev
Publikováno v:
Nature. 577(7790)
Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity1. Structures of active receptors reveal peptide agonists engage deep within the receptor core, leading to an outward movement
Autor:
Andrew Ihor Korytko, J. Jacobs, Andrea E Sperry, John Michael Beals, Jessica L. Friedrich, Amy L. Cox, Steven D. Kahl, Eric D. Hawkins, Julie S. Moyers, Hana E. Baker, Ryan John Hansen, Volker Schellenberger, Chen Zhang, Michael E. Christe, M. Dodson Michael, Debra L. Konkol, D. Bruce Baldwin
Publikováno v:
Diabetes. 67
To optimize the action of exogenously administered insulin, we employed XTEN® technology to create insulins with variably sized XTEN amino acid polymers. Recombinant fusions of XTEN polymers linked to insulin lispro with an A21G mutation were prepar
Autor:
Timothy B. Durham, Jeffrey T. Dixon, James Lee Toth, Angela M. Siesky, Michael E. Christe, Valentine J. Klimkowski, Nathan A. Calvert, John F. Schindler, Dana Sindelar, Kyle W. Sloop, M. Dodson Michael, Jesline T. Alexander-Chacko, Julia X.C. Cao, Ginger Y. Wu, James E. McGee, Rachel N. Cavitt, Stefan Jon Thibodeaux, Sherry Y. Guo, Yong Wang, Michael J. Coghlan, Vladislav V. Kiselyov
Publikováno v:
Journal of Biological Chemistry. 290:20044-20059
Insulin-degrading enzyme (IDE, insulysin) is the best characterized catabolic enzyme implicated in proteolysis of insulin. Recently, a peptide inhibitor of IDE has been shown to affect levels of insulin, amylin, and glucagon in vivo. However, IDE(-/-
Autor:
Guoqing Cao, Patrick I. Eacho, Shuyu Li, James Ficorilli, Michael E. Christe, Angela M. Siesky, Hong Gao, Tonghuan Hu, Laura F. Michael, M. Dodson Michael, Timothy P. Ryan, Patricia S. Foxworthy
Publikováno v:
Endocrinology. 146:5380-5387
Peroxisomes are the exclusive site for the beta-oxidation of very-long-chain fatty acids of more than 20 carbons in length (VLCFAs). Although the bulk of dietary long-chain fatty acids are oxidized in the mitochondria, VLCFAs cannot be catabolized in
Autor:
Mary M. Mader, Michael E. Christe, Xushan Wang, Laura J. Bloem, Jeffrey K. Smallwood, Najia Jin, Theodore Goodson, Arindam Chatterjee, Xiaohong Yu, William F. Matter, John E. Toth, Robert M. Campbell, Chris J. Vlahos
Publikováno v:
Journal of Biological Chemistry. 280:19298-19305
Mixed lineage kinase 7 (MLK7) is a mitogen-activated protein kinase kinase kinase (MAPKKK) that activates the pro-apoptotic signaling pathways p38 and JNK. A library of potential kinase inhibitors was screened, and a series of dihydropyrrolopyrazole
Autor:
Laura F. Michael, James Ficorilli, Keith R. Stayrook, Thomas P. Burris, Michael E. Christe, Todd Cook, Rajesh S. Savkur, Kelli S. Bramlett
Publikováno v:
Endocrinology. 146:984-991
The farnesoid X receptor (FXR; NR1H4) is a nuclear hormone receptor that functions as the bile acid receptor. In addition to the critical role FXR plays in bile acid metabolism and transport, it regulates a variety of genes important in lipoprotein m